How diabetes damages the cardiovascular system, which tests matter most, and how the newest diabetes medications protect your heart — the cardiometabolic guide every diabetic cardiac patient needs.
Most patients with diabetes and heart disease are managed by different specialists who don't coordinate their treatment strategies. The cardiologist manages the heart. The endocrinologist manages the blood sugar. The opportunity to use medications that protect both simultaneously gets missed.
This guide explains the diabetes-heart connection at a depth that empowers you to have that integrated conversation — and to ask whether the cardioprotective diabetes medications are right for you.
Atherosclerosis, cardiomyopathy, neuropathy, dyslipidemia, and hypertension — how each works.
HbA1c, LDL, BP, kidney function, ECG — your complete diabetes-cardiac surveillance schedule.
How empagliflozin and dapagliflozin protect the heart beyond blood sugar control.
Semaglutide, liraglutide — the cardiovascular outcome trial evidence explained.
Why kidney protection in diabetes is cardiac protection — ACE inhibitor strategy.
Evidence-based lifestyle interventions with HbA1c and cardiovascular effect estimates.
"I think of diabetes and heart disease as one condition requiring one comprehensive strategy. The revolution in cardiometabolic medications — SGLT2 inhibitors and GLP-1 agonists — means we now have tools that treat both simultaneously. Every eligible patient should know about them."
The cardiometabolic medications that could protect your heart are waiting.
Get Diabetes-Heart Guide — $37